Post by Hyloris Pharmaceuticals

Warsaw, we're coming. 🗺️ We'll be at euroPLX 91 on June 8–9, 2026 - one of Europe's leading marketplaces for pharma business development. Hyloris Pharmaceuticals specializes in reinventing and repurposing existing medicines to address unmet medical needs. Our portfolio spans hospital injectables, cardiovascular, CNS, pain, and rare disease, built on capital-efficient development and established regulatory pathways like FDA 505(b)(2). We're actively looking for licensing & distribution partners 🤝 ready to bring differentiated specialty pharma assets to new markets. If you're exploring late-stage or ready-to-market opportunities with a proven out-licensing partner, let's connect. 📩 Reach out to schedule a meeting: [email protected] #Hyloris #Health #Pharma #ReinventingMedicines #AddressingUnmetMedicalNeeds #euroPLX91 #Outlicensing #PharmaPartnerships #SpecialtyPharma #Innovation